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The aim of this study was to evidence the clinical eﬃcacy of an alcohol-free mouthwash containing 5.0% (W/V) Brazilian green
propolis (MGP 5%) for the control of plaque and gingivitis. Twenty ﬁve subjects, men and women aging between 18 and 60 years
old (35 ± 9), were included in a clinical trials phase II study who had a minimum of 20 sound natural teeth, a mean plaque index
of at least 1.5 (PI), and a mean gingival index of at least 1.0 (GI). They were instructed to rinse with 10mL of mouthwash test for
1 minute, immediately after brushing in the morning and at night. After 45 and 90 days using mouthwash, the results showed a
signiﬁcant reduction in plaque and in gingival index when compared to samples obtained in baseline. These reductions were at
24% and 40%, respectively (P<. 5). There were no important side eﬀects in soft and hard tissues of the mouth. In this study, the
MGP 5% showed evidence of its eﬃcacy in reducing PI and GI. However, it is necessary to perform a clinical trial, double-blind,
randomized to validate such eﬀectiveness.
1.Introduction
The ﬁrst reference to mouth rinse as a formal practice
is credited to Chinese medicine, about 2700 B.C.E., to
treat the diseases of the gums [2]. The Gram-positive and
Gram-negative bacteria that compose oral bioﬁlms produce
many metabolites that induce gingival inﬂammation (i.e,
gingivitis).Gingivitiscanleadtoperiodontitis,aconditionin
which gingival and bone tissues are destroyed. The majority
of the population may not perform mechanical plaque
removal suﬃciently. Thus, antimicrobial mouth rinses that
improve daily home care may provide an eﬀective way of
removing or controlling bacterial plaque to limit gingivitis
and periodontitis [3]. The main indications are either the
improvement of dental health (plaque and gingivitis elimi-
nation in particular) or the prevention of infections caused
by bacteria of the oral cavity in speciﬁc situations, such as
tooth extraction, intraoral surgical procedures, or immune
suppression due to cancer therapy or transplantation. The
use of antimicrobial mouth rinses has been proposed to
reduce the levels of oral bacteria, especially Streptococcus
mutans[4]. In fact, it has been shown that chemotherapeutic
mouth rinses are an eﬀective adjunct to regular brushing
and ﬂossing for patients with gingivitis, providinga clinically
signiﬁcant beneﬁt in the reduction of plaque and gingivitis
[3]. Propolis is a resinous substance collected by honeybees
from buds and exudates of certain trees and plants and
stored inside their hives. It has been used in folk medicine
from ancient times to treat various ailments [5]. The
action against microorganisms is an essential characteristic
of propolis, and humans have used it for centuries for2 Evidence-Based Complementary and Alternative Medicine
Table 1: Chemical constituents identiﬁed and quantiﬁed (markers) by reverse-phase high-performance liquid chromatography: ﬂavonoids
and other chemical constituent present in a gram of a Brazilian green propolis sample used in handling (SBN 97) [1].
No. COMPOUNDS UNIT (mg/g) RESULTS
1 CUMARINIC ACID mg/g 3.56
2C I N N A M I C A C I D m g / g 1 . 6 6
3Q U E R C E N T I N m g / g 1 . 3 8
4K A E M P F E R O L m g / g 1 . 7 7
5I S O R H A M N E T I N m g / g 0 . 9 1
6 SAKURANETIN mg/g 5.57
7 PINOBANSKIN-3-ACETATE mg/g 13.92
8 CHRYSIN mg/g 3.51
9 GALANGIN mg/g 9.75
10 KAEMPFERIDE mg/g 11.60
11 ARTEPILLIN c mg/g 82.96
(3,5-DIPRENYL-4-HIDROXYCINNAMIC ACID)
its pharmaceutical properties [6]. The antibacterial activity
of propolis is reported due to ﬂavonoids, aromatic acids,
and esters present in resins. Galangin, pinocembrin, and
pinostrobinare knownas the most eﬀectiveﬂavonoidsagents
against bacteria. Ferulic acid and caﬀeic acid also contribute
to the bactericidal action of propolis [7].
The American Dental Association (ADA) Guidelines
(Council on Scientiﬁc Aﬀairs) are applied to products used
for the control of gingivitis and, if applicable, supragingival
dental plaque, through the use of chemotherapeutic agents.
Products that control gingivitis solely by the mechanical
removal of plaque are not considered by these guidelines.
This council believes, that, because plaque is the etiologic
agent for gingivitis and other oral diseases, the only accepted
chemotherapeutic products that will be allowed to make
plaque control or plaque modiﬁcation claims will be those
that can also demonstrate a signiﬁcant eﬀect against gingivi-
tis. If a product can only demonstrate a signiﬁcant plaque
reduction without a concomitant signiﬁcant reduction in
gingivitis, it will not be eligible for acceptance [8]. Thus, the
purpose of this study was to show the clinical evidence, in
subjects, of an alcohol-free mouthwash containing Brazilian
green propolis for the control of plaque and gingivitis for
three months.
2.MaterialandMethods
2.1. Design Study and Product Tested. This was an interven-
tional study of phase II for three months, follow-up type,
and was conducted at the Faculty of Dentistry of Federal
University of Minas Gerais, Brazil, from August 2009 to
April 2010. The alcohol-free mouthwash containing 5% w/v
of Brazilian green propolis (MGP 5%) used in that study
was handled according to our request by Pharma N´ ectar
(Belo Horizonte), within the standards required by ANVISA
[9] and within the requirements of ISO 9001 and GMP
International. Five percent of propolis dry extract (w/v) was
added to a solution containing glycerin, sodium benzoate,
and puriﬁed water. Table 1 shows the amount in mg/g, the
main chemical markers found in green propolis used in the
formulation of the mouthwash study.
2.2.Participants. T wentyﬁvesubjects,ofagevaryingfr om18
to 60 years (median age 35 ± 9), with generally good health,
not pregnant nor breastfeeding, who met the following
inclusion criteria, were included into the study: a minimum
of 20 sound, natural teeth; a mean plaque index (PI) [10]
of at least 1.5; a mean gingival index (GI) [11]o fa t
least 1.0. Subjects with orthodontic appliances or removable
prosthetics, tumors of the soft or hard oral tissues, and
advanced periodontal disease, receiving antibiotic therapy
2 weeks before the beginning of the study, or presenting
hypersensibility to propolis were excluded. Third molars and
those teeth with cervical restorations or prosthetic crowns
were not included in the toothc o u n t .T h es e l e c t i o no f
participants was made by convenience, based especially on
the availability to the study, while the study was conducted.
All subjects read and signed informed consent forms before
the start of the study. The protocol for the study was
approvedby the localethical review committee—Committee
of Bioethics in Research at the Federal University of Minas
Gerais (COEP/UFMG-0600/09), and registered in Clinical-
trials.gov (NCT01142843).
2.3. Assessing Mouthwash. The examination baseline con-
sisted of a complete soft and hard tissues examination that
was performed to register the condition of oral mucosa,
so that any changes in the course of the study could be
identiﬁed, making assessment to whether these changes
could be related to the mouthwash. The gingivitis of the
mesiobuccal, midbuccal, distobuccal, mesiolingual, midlin-
gual, and distolingual of all eligible teeth was scored using
the Talbott modiﬁcation Gingival Index of the L¨ oe-Silness
[11],in which the gumwasscored on a four-point scale from
0 (absence of inﬂammation) to 3 (severe inﬂammation).
The supragingival plaque of the mesiobuccal, midbuccal,
distobuccal, mesiolingual, midlingual, and distolingual of all
eligible teeth was scored using the Turesky modiﬁcation of
the Quigley-Hein Plaque Index [10]. Previously, disclosingEvidence-Based Complementary and Alternative Medicine 3
Table 2: Mean scores of Gingival Index (DP) and percent reduction between periods.
Baseline 45 days 90 days Reduction-%
MGP 5% n = 22 n = 22 n = 21 Baseline–45 days Baseline–90 days 45 days–90 days
1.17 (0.20) 0.64 (0.24) 0.70 (0.18) 45∗ 40∗ —
∗Friedman test (ANOVA) P<. 05.
with erythrosine 3% solution, plaque was scored on a six-
point scale from 0 (no plaque)to 5 (plaquecoverstwo-thirds
or more of the tooth surface). Each tooth was divided into
six areas, three buccal (mesiobuccal, midbuccal, distobuccal)
and three lingual (mesiolingual, midlingual, distolingual),
and the plaque quantiﬁed using the Turesky modiﬁcation
of the Quigley–Hein Plaque Index [10]. There were also
evaluated Severity Plaque Index and Severity Gingival Index
[12, 13]. These index measured the rate of the surface
that had high count of plaque (count similar to 3, 4, 5
of the modiﬁcation Quigley-Hein Plaque Index [10]a n d
high gingival index (count similar to 2, 3 modiﬁcation
Gingival Index of the L¨ oe-Silness [11]. These examinations
were all repeated after 45 and 90 days of the use of
the mouthwash. After baseline examination, each subject
received a complete oral prophylaxis, which included the
removal of all supragingival plaque and calculus deposits.
Soon after, the subjects received an alcohol-free mouthwash
containing 5% green propolis (MGP 5%) and a toothbrush.
Theywereinstructedtobrushtheirteethasusualandtorinse
withthe10mLofMGP5%,twiceaday,foroneminute,right
after their meals in the morning and at night. Participants
were required not to use another mouthwash throughout
the study. When new supplies were issued, subjects returned
their used materials, so that the compliance to the product
could be monitored.
2.4. Reproducibility of Clinical Examinations. All exami-
nations were conducted by a single examiner trained to
optimize the consistency of the study. Prior to the study, the
adviser trained the dental examiner, as a “gold standard,”
directing him to introduce the periodontal probe, gently,
into the gingival sulcus, keeping the instrument parallel to
the long axis of the tooth, sliding it from the distal to the
mesial so delicately in the buccal and lingual surface of each
evaluated tooth. For calibration, there were examined nine
subjects not included in the study. For the plaque index it
was performed a theoretical calibration. Soon after, photos
were used to obtain a standardization intraexaminer. The
photos were exhibited by the adviser to the examiner that
noted the values of plaque index corresponding to each
picture. After 15 days, the same pictures were exposed to
the examiner that registered again the values of the plaque
index.Next,theplaqueindexobtainedintheﬁrst andsecond
timewascomparedtoverifythelevelofintraexaminer. Then,
we obtained a kappa value of 0.73, considered a substantial
estimate of reliability [14].
2.5. Data Analysis. The statistical package BioEstat version
4.0 was used for data analysis in this study. The average
adjusted in the baseline for both scores of the modiﬁed
Plaque Index of Quigley-Hein [10]a n dm o d i ﬁ e dG i n g i v a l
Index of L¨ oe-Silness [11] as for the corresponding severity
scores, for being a nonparametric distribution, was com-
pared through covariance analysis, by Friedman test for data
obtained at 45 and 90 days of the study. All statistical tests of
hypotheses hadtwostrands andasigniﬁcancelevelofP<. 05
was considered [15, 16].
3.Results
During the period available for the development of the
study was carried out a selection for convenience in which
73 patients were eligible. Because of the inclusion and
exclusion criteria and availability, it was only possible to
include a sample of 25 individuals, being in agreement to
what was proposed [17, 18], for phase II trials (Figure 1).
Twenty-one (10 males and 11 females) subjects completed
the period of study. The others left the study for many
reasons: one searched for dental services during the study
and was excluded; another had possible allergy to propolis;
one subject left the study because he felt hypersensibility on
teeth, and one individual was excluded for taking antibiotics
due toillness. Data forthis subject are includedinthe 45-day
analysis.
3.1. Gingivitis and Gingival Severity. The mean baseline
scores of Gingival Index GI, 45 and 90 days, were recorded.
The MGP 5% demonstrated a reduction in gingivitis over
than 40%, being statistically signiﬁcant, comparing to the
scores of 45 and 90 days in the baseline scores (P<. 05).
Although, comparing to the scores of 90 days to 45 days,
there was not a statistically signiﬁcant reduction in gingivitis
(Table 2). The MGP 5% showed a reduction in rate of the
surfacewithscores3,4,and5ofplaqueindex.Thisreduction
was statistically signiﬁcant, (over 70%), comparing the mean
baseline scores with 45 and 90 days (P<. 05). There was not
any statistical signiﬁcance comparing the mean scores of 45
and 90 days (Table 3).
3.2. Plaque and Severity of Plaque. The mean baseline scores
of plaque index (PI), 45 and 90 days, were obtained. Analysis
of variance using the Friedman test was performed with
the baseline scores as covariates, showing that the MGP
5% had an eﬀect on the plaque in the examinations at 45
and 90 days, being statistically signiﬁcant (P<. 05), with
a reduction of 26% and 24%, respectively. However, it did
not obtain signiﬁcant eﬀect on plaque, comparing to the
scores of tests performed on 45 and 90 days (Table 4). In
Severity Plaque Index was observed a statistically signiﬁcant4 Evidence-Based Complementary and Alternative Medicine
Assessed for eligibility n = 73
Excluded n = 48
Not suitable for inclusion criteria n = 30
Refused participation n = 18
Included in the study n = 25
Discontinued the study n = 1
E x c l u d e df r o mt h es t u d ya f t e rt h e2 n d
exam n = 1( a n t i b i o t i cu s e )
Data from 1st and 2nd were used
Excluded from the study before
the 2nd exam n = 2 (allergy, carry
out dental treatment)
Completed the study n = 21
Analysed n = 22 (21 completed the study and a left after the 2nd exam)
Figure 1: Flow diagram about desgining of study.
Table 3: Mean scores of Severity Gengival Index (DP) and percent reduction between periods.
Baseline 45 days 90 days Reduction-%
MGP 5% n = 22 n = 22 n = 21 Baseline–45 days Baseline–90 days 45 days–90 days
0.30 (0.17) 0.08 (0.06) 0.07 (0.03) 73∗ 77∗ 13 (ns)∗∗
∗Friedman test (ANOVA) P<. 05.
∗∗Not signiﬁcant.
diﬀerencecomparingtothemeanbaselinescoreswith45and
90 days. There was a reduction of 41% in the second exam,
remaining the same after the third exam (P<. 05). This
signiﬁcant diﬀerence was not observed in exams performed
on 45 and 90 days (Table 5).
3.3. Oral Mucosa Changes. In the last oral examination
conducted by the researcher was observed, only in one
subject, the presence of an exophytic lesion, located in the
free marginal gum of the labial surface of the element 27.
This lesion had a reddish surface, smooth, bleeding to touch,
measuring 2 × 2mm. Plaque accumulation was observed
around the lesion. Given these facts, it was suggested a
possible diagnosis of pyogenic granuloma. After that, it was
made a supra- and subgingival scaling in this lesion area,
resulting in its complete regression in a period of 15 days.
One patient reported a burning feeling in the oral mucosa
forashort period oftime everytime he used the mouthrinse
during the three months of treatment. Another 3 patients
reported that during the period using mouth rinse they had
a dryness sensation in the mouth.
4.Discussion
This phase II trial study evaluated the action of MGP 5% on
gingivitis and periodontopathogenic plaque.
Clinical trials often present limitations independent on
the eﬀorts of the researchers. This study has limitations as
the presence of unexpected reactions to the product and as a
probable allergic reaction, that did not deserve any concern,
but resulted in the exclusion of an individual and decreased
the sample. Another limitation was the diﬃculty to control
the compliance to the study, how to get in touch with them
every time they needed to return for evaluation. Despite the
imposition of a control-use mouthwash (return the empty
bottle), clinical trials have limitations with respect to the
veracity of the suitability of t h ep r o d u c tb yp a t i e n t st h a ta r e
generally beyond the control of the researcher. The MGP 5%
produced signiﬁcant reductions in supragingival plaque and
gingivitis as adjunct to the oral hygiene procedures, when
comparedtobaseline scoresindexwith45and90days.These
ﬁndings are probably justiﬁed by the antibacterial and anti-
inﬂammatory eﬀects of propolis. The reduction of number
of microorganisms in dental plaque resulted in decreasing
of bulk. There are some studies in vitro and in vivo where
propolis, in several formulations, has demonstrated activity
against periodontal pathogens [19–21]. The antimicrobial
property of Brazilian propolis is attributed to the presence of
ﬂavonoids, phenolic acids, and their prenylated derivatives
on its composition. Propolis has a complex chemical com-
position, considering the type of bee that produced it, the
origin,andseasonsofcollection.Moreover,itsactionisdose-
time dependent, and, in this study, we took into account
the time of use, evaluation times, and the concentration of
the mouth rinse. Some components present in propolis as
ﬂavonoids (quercetin, galangin, and pinocembrin), caﬀeic
acid, benzoic acid, and cinnamic acid, probably act on the
microbial membrane or surface of the cell wall, causing
structural and functional damage [22]. Synergistic eﬀects
of diﬀerent compounds seem to be the most importantEvidence-Based Complementary and Alternative Medicine 5
Table 4: Mean scores of Plaque Index (DP) and percent reduction between periods.
Baseline 45 days 90 days Reduction-%
MGP 5% n = 22 n = 22 n = 21 Baseline–45 days Baseline–90 days 45 days–90 days
2.39 (0.69) 1.77 (0.61) 1.82 (0.62) 26∗ 24∗ —
∗Friedman test (ANOVA) P<. 05.
Table 5: Mean scores of Severity Plaque Index (DP) and percent between periods.
Baseline 45 days 90 days Reduction-%
MGP 5% n = 22 n = 22 n = 21 Baseline–45 days Baseline–90 days 45 days–90 days
0.44 (0.19) 0.26 (0.14) 0.26 (0.15) 41∗ 41∗ —
∗Friedman test (ANOVA) P<. 05.
process to explain the antibacterial activity of propolis, since
it is well established that a single propolis component does
not have an activity greater than the other components of
propolis isolated [19]. This study used the green propolis,
derived from Baccharis dracunculifolia,an a t i v ep l a n to f
southeastern Brazil [23]. This kind of propolis has as its
main bioactive compounds the artepillin C and others
compounds as coumarinic acids that are probably related to
anti-inﬂammatory and antibacterial properties, respectively.
The artepillin C, in other studies, showed potential anti-
inﬂammatory activity [24–26]. Other components presented
in green propolis might be involved in anti-inﬂammatory
eﬀects observed on its results. Propolis, to produce the anti-
inﬂammatory eﬀect, acts in the modulation of cytokines
and inﬂammatory enzymes, such as the suppression of the
production of prostaglandins, leukotrienes, histamine, and
TGF-β1[ 26, 27]. Reducing the number of microorganisms
in dental plaque results in the reduction of products released
b yt h e m ,w h i c ha c ta st r i g g e ro fg i n g i v a li n ﬂ a m m a t i o n .T h e
results of MGP 5% on the severity of plaque and gingival
indexes suggest that the anti-inﬂammatory eﬀect on the
gingival condition of subjects was greater than the eﬀect
of reducing plaque, due to the higher decrease of bleeding
points than the decrease of plaque.
The treatment period of 3 months was chosen because
of gingivitis is a chronic disease and because there was
no interference in the habits of hygiene of the individuals
involved in the study. In this study, we applied an approach
close to the required standards by the ADA for testing new
products for use in the oral cavity. The ADA general purpose
for such products and methods is to assist the identiﬁcation
of sites or subjects with existing periodontitis or at increased
risk of periodontitis, or the development or progression
of periodontitis. Clinical use of such diagnostics might
occur (1) during initial evaluation (screening, pretreatment
risk assessment, diagnosis, and treatment planning); (2)
during treatment or management (monitoring therapeutic
endpoints and identifying therapeutic targets), and (3)
posttreatment (establishment of recall intervals and early
detection of recurrent disease). The speciﬁcs of clinical
trial design for each of these related, but separate, clinical
functions may diﬀerdependingona varietyofcircumstances
[28].
As a phase II study, there is not a crucial requirement in
relation to time of study [29, 30]. The concentration of 5%
was chosen considering that propolis is a resinous substance
that, at higher concentrations, could cause its precipitation
in the bottle, staining the teeth and, as a result, not being
accepted by patients due to the strong ﬂavor. So far, there
are not any clinical studies that evaluated the oral rinse of
propolison thebasisofplaqueandgingivitis controlforsuch
alongperiod,aswedid[29,31,32].Duringthethreemonths
of study, oral examinations were performed in recalls after
t h eb a s e l i n ee x a m i n a t i o n ,a n do n ep a t i e n th a dap y o g e n i c
granuloma in the buccal marginal gum of the element 27.
This probably occurred because the patient did not have an
appropriate oral hygiene, as veriﬁed by oral examination,
according to the presence of plaque accumulation in this
tooth. The plaqueremoval by scaling, supra- and subgingival
plaque, and the regression of the lesion after 15 days support
this hypothesis [33]. Those subjects, who reported dryness
mouth and rough, probably had that feeling because the
ingestion of water was not enough to body hydration.
Moreover, these patients were female and were in the age
group corresponding to the period of menopause. When the
subject started to drink the required amount of water, the
feeling disappeared. Although the MGP 5% is alcohol-free,
there was one patient who reported a burning feeling when
using the mouth rinse for three months. Probably, this fact
was due to the concentration of the mouthwash being 5%,
which has a strong ﬂavor, while the other participants have
not reported the same. In intraoral examination, this patient
had no mucosal irritation.
More recently, for various reasons, there has been an
increase in the demand for alcohol-free mouthwashes. The
reason for not including alcohol in the mouthwash was
initially based on both social and health reasons. Social
reasons include religious objections and the potential for
detecting alcohol in the breath. Additionally, it has been
recognized that some individuals’ oral mucosa is sensitive
to alcohol, with some evidence to show that discomfort
increases linearly with increasing concentrations of alco-
hol. Other potential problems with alcohol rinses include
the softening and reduced color stability of tooth-colored
restorations and the possible increased risk of developing
oral cancer [34].6 Evidence-Based Complementary and Alternative Medicine
5.Conclusions
The present study showed evidenceof theeﬃcacy ofalcohol-
free mouthwash containing 5% of Brazilian green propolis
for the control of plaque and gingivitis, suggesting that it
can be used as a therapeutic and preventive use for the
control of periodontal diseases. However, it is necessary to
perform a clinical trial, double-blind, randomized according
to the requirements of the Council on Dental Therapeutics
of the American Dental Association (ADA) to prove the
eﬃcacy of an alcohol-free mouthwash containing 5% w/v of
Braziliangreenpropolisfortheuseofthisproducttobecome
customary in dentistry.
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